Clover Health Investments (CLOV) Q3 2024 earnings summary

Executive summary

• Achieved 9% year-to-date revenue growth and significant adjusted EBITDA profitability, with net loss from continuing operations narrowing to $8.8 million in Q3 and $20.9 million year-to-date, reflecting strong operational execution and cost controls.

• Adjusted EBITDA reached $19.3 million in Q3 2024 and $62.3 million year-to-date, up $87.2 million year-over-year.

• Flagship PPO plan achieved a 4.0 Star rating for payment year 2026, with over 95% of members in 4+ Star plans, supporting future growth and quality bonus payments.

• Launched Counterpart Health, a SaaS and tech-enabled services subsidiary, and exited the ACO REACH Program, with related results now reported as discontinued operations.

• Positioned for long-term Medicare Advantage growth as competitors retreat due to lower Star Ratings and cost pressures, leveraging technology-driven care management.

Financial highlights

• Q3 2024 insurance revenue grew 7% year-over-year to $323 million; year-to-date insurance revenue reached $1.04 billion, up 9%.

• Gross profit for the insurance segment was $75 million in Q3 and $259 million year-to-date, up 39% year-over-year.

• Insurance MCR improved to 78.0% in Q3 2024 and 75.6% year-to-date; BER improved to 82.8% in Q3 and 80.6% year-to-date.

• Adjusted SG&A decreased 8% year-over-year to $61.9 million in Q3 2024; YTD Adjusted SG&A down 4%.

• Cash, cash equivalents, and investments totaled $531.4 million at quarter end.

Outlook and guidance

• Full-year 2024 insurance revenue expected between $1.25–$1.375 billion, tracking toward the lower end due to member mix shifts.

• Insurance MCR guidance improved to 76–77%; BER guidance to 81–82%.

• Adjusted SG&A guidance raised to $290–$295 million, reflecting growth and quality investments.

• Increased full-year 2024 adjusted EBITDA guidance to $55–$65 million.

• CMS's 4-Star rating for PPO plans in 2025 is expected to result in a 5% quality bonus increase in benchmark rates for payment year 2026.